The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

The cutting-edge technology used in COVID-19 shots may lead to new treatments for other diseases. But some conservatives are ...

Scientists at Cornell University have developed a new type of vaccine that may provide stronger and longer-lasting protection ...

The new vaccine addresses significant limitations of existing COVID-19 and flu vaccines. While mRNA COVID-19 vaccines require ...

Vaccine hesitancy was rising even before COVID-19 emerged – but the pandemic exacerbated the trend. More kindergartners are ...

Among nearly 700,000 adults ages 65 and older, the receipt of nine different intervention letters focused on increasing ...

Lessons learned from COVID-19 prepared the U.S. for the next viral scourge, but much of that progress is at risk of being ...

RSV is still a threat, but Corewell Health’s downtown Grand Rapids children’s hospital is feeling the effects of one of ...

Cornell researchers have developed a stable, multi-target vaccine offering long-lasting protection against COVID-19 and influenza, with promising results in mice. Cornell University researchers have ...

Since 2019, childhood vaccination rates in Michigan have decreased nearly 10%. Still, about 70% of Americans received the ...

On a table at the back of Phoebe Lostroh’s classroom at Colorado College whirs a constant reminder that pandemics are not ...

The 2024-2025 COVID-19 and influenza vaccines provided protection against ED/UC, outpatient visits, and hospitalizations. In the 2024-2025 season, the COVID-19 vaccine provided additional ...